Document Detail


Environmental estrogens and reproductive health: a discussion of the human and environmental data.
MedLine Citation:
PMID:  9241667     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Estrogenic activity of certain xenobiotics is an established mechanism of toxicity that can impair reproductive function in adults of either sex, lead to irreversible abnormalities when administered during development, or cause cancer. The concern has been raised that exposure to ambient levels of estrogenic xenobiotics may be having widespread adverse effects on reproductive health of humans and wildlife. The purpose of this review is to evaluate (a) the nature of the evidence supporting this concern, and (b) the adequacy of toxicity screening to detect, and risk assessment procedures to establish safe levels for, agents acting by this mechanism. Observations such as adverse developmental effects after maternal exposure to therapeutic levels of the potent estrogen diethylstilbestrol or male fertility problems after exposure to high levels of the weak estrogen chlordecone clearly demonstrate that estrogenicity is active as a toxic mechanism in humans. High level exposures to estrogenic compounds have also been shown to affect specific wildlife populations. However, there is little direct evidence to indicate that exposures to ambient levels of estrogenic xenobiotics are affecting reproductive health. Reports of historical trends showing decreasing reproductive capacity (e.g., decreased sperm production over the last 50 years) are either inconsistent with other data or have significant methodologic inadequacies that hinder interpretation. More reliable historical trend data show an increase in breast cancer rate, but the most comprehensive epidemiology study to data failed to show an association between exposure to persistent, estrogenic organochlorine compounds and breast cancer. Clearly, more work needs to be done to characterize historical trends in humans and background incidence of abnormalities in wildlife populations, and to test hypotheses about ambient exposure to environmental contaminants and toxic effects, before conclusions can be reached about the extent or possible causes of adverse effects. It is unlikely that current lab animal testing protocols are failing to detect agents with estrogenic activity, as a wide array of estrogen-responsive endpoints are measured in standard testing batteries. Routine testing for aquatic and wildlife toxicity is more limited in this respect, and work should be done to assess the validity of applying mammalian toxicology data for submammalian hazard identification. Current risk assessment methods appear to be valid for estrogenic agents, although the database for evaluating this is limited. In conclusion, estrogenicity is an important mechanism of reproductive and developmental toxicity; however, there is little evidence at this point that low level exposures constitute a human or ecologic health risk. Given the potential consequences of an undetected risk, more research is needed to investigate associations between exposures and effects, both in people and animals, and a number of research questions are identified herein. The lack of evidence demonstrating widespread xenobiotic-induced estrogenic risk suggests that far-reaching policy decisions can await these research findings.
Authors:
G P Daston; J W Gooch; W J Breslin; D L Shuey; A I Nikiforov; T A Fico; J W Gorsuch
Related Documents :
22116377 - Oncolytic poxvirus armed with fas ligand leads to induction of cellular fas receptor an...
12798527 - A randomized placebo-controlled crossover trial with phytoestrogens in treatment of men...
14962527 - Habits (hormonal replacement therapy after breast cancer--is it safe?), a randomised co...
21037107 - Confounding effects of hormone replacement therapy in protein biomarker studies.
17591297 - A comparison of preoperative airway assessment techniques: the modified mallampati and ...
11773297 - Is her2 of value in identifying patients who particularly benefit from anthracyclines d...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Reproductive toxicology (Elmsford, N.Y.)     Volume:  11     ISSN:  0890-6238     ISO Abbreviation:  Reprod. Toxicol.     Publication Date:    1997 Jul-Aug
Date Detail:
Created Date:  1997-09-09     Completed Date:  1997-09-09     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  8803591     Medline TA:  Reprod Toxicol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  465-81     Citation Subset:  IM    
Affiliation:
American Industrial Health Council, Reproductive & Developmental Effects Subcommittee, Washington, DC, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Environmental Pollutants / toxicity*
Estrogens / toxicity*
Female
Humans
Male
Reproduction / drug effects*
Risk Assessment
Chemical
Reg. No./Substance:
0/Environmental Pollutants; 0/Estrogens

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Relationship between human genotype and phenotype of N-acetyltransferase (NAT2) as estimated by disc...
Next Document:  Valproate-induced limb malformations in mice associated with reduction of intracellular pH.